Cantor Fitzgerald Maintains Overweight on Core Scientific, Raises Price Target to $29

Cantor Fitzgerald analyst Brett Knoblauch maintains Core Scientific (NASDAQ:CORZ) with a Overweight and raises the price target from $25 to $29.